We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best ...

Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. ("Cerevel Therapeutics Holdings, Inc." or the "Company") of a class action securities ...

Zacks Research just trimmed its FY2025 earnings forecast for AbbVie, shaving it from $12.14 to $12.02 per share. This modest ...

Top local executive of Allergan Aesthetics Carrie Strom announces her departure from the AbbVie-owned company.

AbbVie Inc. has earned a spot among the elite Dividend Monarchs by raising dividends for 52 straight years—a feat worthy of a ...

A recent selloff of Neurocrine Biosciences stock feels unwarranted and may have created a contrarian buy opportunity. Learn ...

Shares of AbbVie Inc. ABBV shed 2.90% to $171.68 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and Dow ...

We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look ...

NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Cerevel Therapeutics Holdings, Inc. (NYSE:ABBV) investment and ...

With broadcasts of the college football and NFL playoffs, as well as the men’s and women’s college basketball tournaments, many drugmakers looked to sports for advertising opportunities in Q1.

According to Capitol Trades, a platform that shares politician trading data, Greene invested $100,000-$250,000 on U.S.